echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Express | Open up a new model of targeted RNA, Janssen reached a cooperation of over 1 billion US dollars

    Express | Open up a new model of targeted RNA, Janssen reached a cooperation of over 1 billion US dollars

    • Last Update: 2022-03-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 17, 2022, Remix Therapeutics announced an R&D collaboration with Janssen, a subsidiary of Johnson & Johnson, to use Remix's REMaster drug discovery platform to develop small molecule therapeutics that modulate RNA processing


    Traditional drug development treats diseases by regulating the activity of proteins or enzymes related to diseases.


    Image source: Remix's official website

    Remix employs a novel strategy to treat diseases by reprogramming RNA processing


    Image source: Remix's official website

    Under the terms of the agreement, Remix will receive up to $45 million in upfront payments and research funding, and may receive preclinical, clinical, and commercialization milestone payments, as well as future tiered royalties on any resulting products, the potential total amount may be over $1 billion


    Dr.


    English original link: https:// rna-processing/

    https://
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.